Views & Analysis Europe has untapped medical innovation – but needs high spee... The head of Johnson & Johnson (J&J) Innovation in Europe says the region is ripe for more life sciences investment, but warns that the UK, its biotech leader, could miss out withou
News Teva makes its first M&A play in years, buying Emalex Teva has made its first pipeline-building acquisition in almost a decade, buying Tourette syndrome drug developer Emalex for up to $900m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
